Relationship between serum lipoprotein(a) level and thrombin generation to the circadian variation in onset of acute myocardial infarction (Q73551754)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11223439%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Relationship between serum lipoprotein(a) level and thrombin generation to the circadian variation in onset of acute myocardial infarction (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11223439%20AND%20SRC:MED&resulttype=core&format=json

acute myocardial infarction

4 November 2019

main subject

1 reference

T Fujino

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11223439%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

J Katou

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11223439%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

M Fujita

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11223439%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

T Ohta

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11223439%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

T Harada

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11223439%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

N Hasebe

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11223439%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

K Kikuchi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11223439%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 March 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11223439%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11223439%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

155

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11223439%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11223439%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

171-178

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11223439%20AND%20SRC:MED&resulttype=core&format=json

Circadian variation in the frequency of onset of acute myocardial infarction

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900531-1

Modifiers of timing and possible triggers of acute myocardial infarction in the Thrombolysis in Myocardial Infarction Phase II (TIMI II) Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900531-1

Increased morning incidence of myocardial infarction in the ISAM Study: absence with prior beta-adrenergic blockade. ISAM Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900531-1

Effect of autonomic nervous system dysfunction on the circadian pattern of myocardial ischemia in diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900531-1

Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900531-1

Circadian variation in the efficacy of tissue-type plasminogen activator.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900531-1

Morning resistance to thrombolytic therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900531-1

cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900531-1

Proliferation of human smooth muscle cells promoted by lipoprotein(a)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900531-1

Atherogenesis in transgenic mice expressing human apolipoprotein(a)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900531-1

A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900531-1

Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900531-1

Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900531-1

Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900531-1

Circadian variation of sudden cardiac death reflects age-related variability in ventricular fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900531-1

The clinical outcome of acute myocardial infarction is related to the circadian rhythm of myocardial infarction onset

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900531-1

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900531-1

Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900531-1

Tissue-type plasminogen activator binds to and is inhibited by surface-bound lipoprotein(a) and low-density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900531-1

The mysteries of lipoprotein(a)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900531-1

Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900531-1

Circadian variation of tissue plasminogen activator and its inhibitor, von Willebrand factor antigen, and prostacyclin stimulating factor in men with ischaemic heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900531-1

Circadian variation in platelet function in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900531-1

Increased thrombin levels during thrombolytic therapy in acute myocardial infarction. Relevance for the success of therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900531-1

Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. Hirulog Angioplasty Study Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900531-1

A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900531-1

A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. Helvetica Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900531-1

Opposing effects of plasma epinephrine and norepinephrine on coronary thrombosis in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900531-1

Circadian variations of plasma catecholamine, cortisol and immunoreactive insulin concentrations in supine subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900531-1

Tissue plasminogen activator and other risk factors as predictors of cardiovascular events in patients with severe angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900531-1

Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease. A 7-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900531-1

Oxidative modification enhances lipoprotein(a)-induced overproduction of plasminogen activator inhibitor-1 in cultured vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900531-1

Oxidative modification of Lp(a) causes changes in the structure and biological properties of apo(a).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900531-1

Acute reduction of lipoprotein(a) by tissue-type plasminogen activator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900531-1

Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900531-1

Plasminogen activator and plasminogen activator inhibitor I release during experimental endotoxaemia in chimpanzees: effect of interventions in the cytokine and coagulation cascades.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900531-1

Plasminogen activator inhibitor-1 and vitronectin promote the cellular clearance of thrombin by low density lipoprotein receptor-related proteins 1 and 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900531-1

Serum lipoprotein(a) level is related to thrombin generation and spontaneous intermittent coronary occlusion in patients with acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900531-1

Lipoprotein(a), fibrin binding, and plasminogen activation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900531-1

inferred from DOI database lookup

7 January 2021

based on heuristic

In vitro studies of the interaction of isolated Lp(a) lipoprotein and other serum lipoproteins with glycosaminoglycans

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2800%2900531-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0021-9150(00)00531-1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11223439%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference